Mattsson L A, Cullberg G
Acta Obstet Gynecol Scand. 1983;62(5):393-6. doi: 10.3109/00016348309154208.
In a comparative randomized cross-over study the absorption of a single dose of 0.5 mg estriol from a vaginal cream or a vaginal suppository (OvestinR, Organon, The Netherlands) was studied. Eight healthy postmenopausal women participated and the preparations were given with an interval of 14 days. Blood sampling was performed twice before application and then after 1/4, 1/2, 1, 2, 4, 6, 8, 24 and 48 hours. Serum was analysed for unconjugated and conjugated estriol (E3), FSH and LH by radio-immunoassay. Considerable interindividual variations in serum levels of unconjugated E3 were found but mean values were about equal throughout the study for the two preparations. Peak levels of 0.5-0.6 nmol/l were achieved 1-2 hours after application of the preparations and after 24 hours no unconjugated E3 was measurable. Conjugated E3 rose rapidly but within 48 hours serum concentrations reached baseline levels. A maximum decrease in serum LH levels of about 40% was obtained with both preparations after 6 hours and the return to baseline within 24 hours indicates a relationship to unconjugated E3. FSH in serum was maximally suppressed 6-12%. Estriol is thus readily absorbed by the vaginal route and peak levels of unconjugated E3 after insertion of 0.5 mg estriol seem to be comparable to those obtained after 8-12 mg estriol given orally.
在一项比较性随机交叉研究中,对单次剂量0.5毫克雌三醇经阴道乳膏或阴道栓剂(OvestinR,荷兰欧加农公司)的吸收情况进行了研究。八名健康绝经后女性参与了研究,两种制剂给药间隔为14天。在用药前进行两次血样采集,然后在用药后1/4、1/2、1、2、4、6、8、24和48小时进行血样采集。通过放射免疫分析法对血清中的游离雌三醇(E3)、结合雌三醇、促卵泡生成素(FSH)和促黄体生成素(LH)进行分析。发现游离E3血清水平存在显著个体差异,但在整个研究过程中,两种制剂的平均值大致相等。制剂用药后1 - 2小时达到0.5 - 0.6纳摩尔/升的峰值水平,24小时后无法检测到游离E3。结合E3迅速上升,但48小时内血清浓度恢复到基线水平。两种制剂用药6小时后血清LH水平最大降幅约为40%,24小时内恢复到基线水平表明其与游离E3有关。血清FSH最大抑制率为6 - 12%。因此,雌三醇经阴道途径易于吸收,插入0.5毫克雌三醇后游离E3的峰值水平似乎与口服8 - 12毫克雌三醇后的峰值水平相当。